Lariat Biosciences, Inc. is an employee-owned biotechnology start-up, situated at the North Shore Innoventures incubator in Beverly, MA. Lariat was founded in 2013 by Jonathan Larson with the long term vision of curing cancer by early stage screening. All of Lariat’s core competencies in research and development were developed in-house, ranging from our biochemical methods for identifying rare cancer-causing genetic variants to our microfluidic chip technologies on which our biochemistry relies. Support for these accomplishments have been provided by grant funding (see News) and also by a variety of strategic consulting projects pulling from Lariat’s intellectual property.
Jonathan is highly interdisciplinary entrepreneur, research scientist, and microfluidics engineer with fifteen years of experience in biotechnology start-ups. He is proficient in biophysics and physics with a working knowledge that spans into bio-, electro-, and photochemistry plus polymer physics. In addition to these scientific skills, he is also experienced with software and firmware programming, electronics, and especially microfluidic circuit design. Prior to founding Lariat, Jonathan commercialized three different microfluidic chips, integrated numerous DNA manipulations into a single lab-on-a-chip, and developed many specialized laboratory instruments. Jonathan received his PhD in Biophysics from the University of Illinois at Urbana-Champaign.